Diabetic Neuropathy: Causes, Risk Factors & Prevention

Diabetic neuropathy is nerve damage caused by chronic hyperglycemia in diabetes mellitus. It affects ~50% of people with diabetes long-term and is the leading cause of non-traumatic limb amputation.

Pathophysiology

  • Metabolic: Polyol pathway flux (sorbitol accumulation → osmotic stress), AGE formation, PKC activation, hexosamine pathway.
  • Vascular: Endothelial dysfunction → capillary basement membrane thickening → endoneurial hypoxia/ischemia.
  • Neurotrophic: Impaired NGF/NT-3 signaling → axonal degeneration.
  • Oxidative Stress & Inflammation: Mitochondrial dysfunction, microglial activation.

Clinical Patterns

  • Distal Symmetric Polyneuropathy (DSPN): 75% — stocking-glove sensory loss, pain, paresthesia.
  • Autonomic Neuropathy: Gastroparesis, orthostatic hypotension, neurogenic bladder, sexual dysfunction, cardiac denervation (silent MI).
  • Focal/Mononeuropathy: Cranial nerves (III, IV, VI), median (carpal tunnel), femoral, lateral femoral cutaneous.
  • Proximal Motor Neuropathy (Amyotrophy): Asymmetric thigh/hip pain, weakness, wasting.

Risk Factors (Modifiable & Non-Modifiable)

Prevention & Disease-Modifying Strategies

  1. Glycemic Control: HbA1c <7% (individualized) — DCCT/UKPDS: 60% risk reduction for DSPN with intensive control.
  2. Multifactorial Risk Reduction: Statin, ACEi/ARB, BP <130/80, smoking cessation, weight management.
  3. Annual Screening: 10g monofilament, vibration (128 Hz tuning fork), pinprick, ankle reflexes. Symptom questionnaires (MNSI, DN4).
  4. Foot Care: Daily inspection, proper footwear, podiatry — prevents ulcers/amputation.
  5. B12 Monitoring: Annual if on metformin >3–4 years; supplement if deficient.
  6. Pathophysiology-Targeted Therapies (Emerging): Aldose reductase inhibitors, AGE breakers, PKC-β inhibitors, Nrf2 activators — clinical trials ongoing.

Symptomatic Treatment (Painful DSPN)

  • First-line: Duloxetine, pregabalin, gabapentin.
  • Second-line: TCAs (amitriptyline), topical capsaicin/ lidocaine, tramadol (cautiously).
  • Non-pharmacologic: TENS, acupuncture, exercise.

Early, sustained glycemic control is the single most powerful intervention. Neuropathy is often silent until advanced—proactive screening saves limbs and lives.

Diabetes - Related Articles

Health Sciences © https://www.222health.com

Non-ModifiableModifiable
Duration of diabetesGlycemic control (HbA1c)
Age >50Hypertension
Genetic susceptibilityDyslipidemia
Male sex (higher DSPN risk)Obesity / Central adiposity
Smoking
Alcohol excess
Vitamin B12 deficiency (metformin-associated)
CKD / ESRD